Connection

Daniel Judge to Calcium Channel Blockers

This is a "connection" page, showing publications Daniel Judge has written about Calcium Channel Blockers.
Connection Strength

0.689
  1. Judge DP. Why should cardiologists consider genetic testing for hypertrophic cardiomyopathy? JACC Heart Fail. 2015 Feb; 3(2):189-91.
    View in: PubMed
    Score: 0.527
  2. Doyle JJ, Doyle AJ, Wilson NK, Habashi JP, Bedja D, Whitworth RE, Lindsay ME, Schoenhoff F, Myers L, Huso N, Bachir S, Squires O, Rusholme B, Ehsan H, Huso D, Thomas CJ, Caulfield MJ, Van Eyk JE, Judge DP, Dietz HC. A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome. Elife. 2015 10 27; 4.
    View in: PubMed
    Score: 0.141
  3. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med. 2008 Jun 26; 358(26):2787-95.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.